1. Fradet, Anaïs, Fitzgerald, Jamie. 2016. INPPL1 gene mutations in opsismodysplasia. In Journal of human genetics, 62, 135-140. doi:10.1038/jhg.2016.119. https://pubmed.ncbi.nlm.nih.gov/27708270/
2. Ando, Kunie, Küçükali, Fahri, Doeraene, Emilie, Brion, Jean-Pierre, Leroy, Karelle. 2024. Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. In Acta neuropathologica, 147, 94. doi:10.1007/s00401-024-02745-7. https://pubmed.ncbi.nlm.nih.gov/38833073/
3. Wei, Wei, Geer, Mitchell J, Guo, Xinyi, Sanjana, Neville E, Neel, Benjamin G. 2023. Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20221563. https://pubmed.ncbi.nlm.nih.gov/36820830/
4. Zhou, Yi-Li, Zheng, Chen, Chen, Yi-Tong, Chen, Xue-Min. 2018. Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma. In OncoTargets and therapy, 11, 7725-7731. doi:10.2147/OTT.S185803. https://pubmed.ncbi.nlm.nih.gov/30464521/
5. Marion, Evelyne, Kaisaki, Pamela Jane, Pouillon, Valérie, Gauguier, Dominique, Schurmans, Stéphane. . The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. In Diabetes, 51, 2012-7. doi:. https://pubmed.ncbi.nlm.nih.gov/12086927/